Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Gains from Investment Securities (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Gains from Investment Securities for 16 consecutive years, with -$5.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities changed N/A year-over-year to -$5.1 million, compared with a TTM value of -$5.7 million through Dec 2025, down 292.13%, and an annual FY2025 reading of -$5.7 million, down 292.13% over the prior year.
  • Gains from Investment Securities was -$5.1 million for Q4 2025 at Cross Country Healthcare, down from -$2.4 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $5.0 million in Q3 2022 and bottomed at -$5.9 million in Q3 2023.
  • Average Gains from Investment Securities over 5 years is -$31764.7, with a median of -$202000.0 recorded in 2024.
  • Peak annual rise in Gains from Investment Securities hit 8665.22% in 2021, while the deepest fall reached 1446.97% in 2021.
  • Year by year, Gains from Investment Securities stood at -$995000.0 in 2021, then surged by 599.1% to $5.0 million in 2022, then plummeted by 105.01% to -$249000.0 in 2023, then soared by 1451.41% to $3.4 million in 2024, then plummeted by 250.79% to -$5.1 million in 2025.
  • Business Quant data shows Gains from Investment Securities for CCRN at -$5.1 million in Q4 2025, -$2.4 million in Q3 2025, and $1.8 million in Q2 2025.